Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis

por Rubin, David T., Modesto, Irene, Vermeire, Séverine, Danese, Silvio, Ng, Siew C., Kwok, Kenneth K., Koram, Nana, Jones, Thomas V.
Publicado 2021

Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme

por Sandborn, William J., Panés, Julian, Sands, Bruce E., Reinisch, Walter, Su, Chinyu, Lawendy, Nervin, Koram, Nana, Fan, Haiyun, Jones, Thomas V., Modesto, Irene, Quirk, Daniel, Danese, Silvio
Publicado 2019

Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database Wi...

por Curtis, Jeffrey R, Regueiro, Miguel, Yun, Huifeng, Su, Chinyu, DiBonaventura, Marco, Lawendy, Nervin, Nduaka, Chudy I, Koram, Nana, Cappelleri, Joseph C, Chan, Gary, Modesto, Irene, Lichtenstein, Gary R
Publicado 2020